Skip to main content

Table 2 miTNM stages by tracer

From: Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis

miTNM stage

[18F]-F-PSMA-1007 [n]

[68Ga]-Ga-PSMA-11 [n]

T

 T0

26 (56.5%)

26 (56.5%)

 R

7 (15.2%)

7 (15.2%)

 T2u

5 (10.9%)

4 (8.7%)

 T2m

3 (6.5%)

4 (8.7%)

 T3a

1 (2.2%)

1 (2.2%)

 T3b

2 (4.3%)

2 (4.3%)

 T4

2 (4.3%)

2 (4.3%)

N

 N0

32 (69.6%)

32 (69.6%)

 N1

7 (15.2%)

10 (21.7%)

 N2

7 (15.2%)

4 (8.7%)

M

 0

27 (58.7%)

28 (60.9%)

 1a

4 (8.7%)

4 (8.7%)

 1b

12 (26.1%)

11 (23.9%)

 1c

3 (6.5%)

3 (6.5%)

  1. T2u (unifocal) T2m (multifocal)
  2. Differences between both tracers were marked in bold